Company / Operating Margin
UTAH MEDICAL PRODUCTS INC Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
33.4%
FY2025
5-year range
33.4% / 125.7%
FY2021-FY2025
Trend
-11.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has declined for 3 consecutive years, from 125.7% in FY2022 to 33.4% in FY2025.
Based on SEC 10-K filings.
33.4% in FY2025 with a 5-year CAGR of -11.1%.
Declined from 38.5% to 33.4% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -92.3pp
- 5-Year Change
- -11.1pp
- 10-Year Change
- -
Key checks
Key Insights
- UTAH MEDICAL PRODUCTS INC's operating margin has declined for 3 consecutive years.
- In FY2025, operating margin decreased 11.8% year-over-year.
- Peak operating margin was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 33.4% | -11.8% |
| FY2024 | 37.9% | -1.7% |
| FY2023 | 38.5% | -69.4% |
| FY2022 | 125.7% | +234.5% |
| FY2021 | 37.6% | -15.6% |
| FY2020 | 44.5% | -3.0% |
| FY2019 | 45.9% | +11.4% |
| FY2018 | 41.2% | +5.7% |
| FY2017 | 39.0% | -0.7% |
| FY2016 | 39.3% | +7.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026